Results 211 to 220 of about 187,741 (262)

Klotho-derived peptide 1 ameliorates hepatic fibrosis induced by αKlotho deficiency and liver injury. [PDF]

open access: yesInt J Biol Sci
Tan H   +10 more
europepmc   +1 more source

Hepatic fibrosis—Overview

Toxicology, 2008
The study of hepatic fibrosis, or scarring in response to chronic liver injury, has witnessed tremendous progress in the past two decades. Clarification of the cellular sources of scar, and emergence of hepatic stellate cells not only as a fibrogenic cell type, but also as a critical immunomodulatory and homeostatic regulator are among the most salient
Scott L Friedman
exaly   +3 more sources

Markers of hepatic fibrosis

Medicina Clínica (English Edition), 2018
Chronic liver diseases constitute a major health problem. Chronic liver inflammation, defined by the degree of hepatic fibrosis, is asymptomatic in a significant percentage of patients; hence, the disease often remains undiagnosed until it has reached very advanced phases and, frequently, when the damage is irreversible.
Llorenç, Caballería   +2 more
openaire   +2 more sources

Imaging of Hepatic Fibrosis

Current Gastroenterology Reports, 2018
The purpose of this review is to discuss the current imaging techniques for non-invasive assessment of liver fibrosis (LF).Elastography-based techniques are the most widely used imaging methods for the evaluation of LF. Currently, MR elastography (MRE) is the most accurate non-invasive method for detection and staging of LF.
Rishi Philip, Mathew   +1 more
openaire   +2 more sources

Hepatic fibrosis in the mucopolysaccharidoses

The American Journal of Medicine, 1986
The mucopolysaccharidoses are a group of clinically progressive, heritable, lysosomal storage disorders. Many organ systems are affected due to widespread accumulation of incompletely degraded mucopolysaccharide. The novel finding of hepatic fibrosis in each of six cases of mucopolysaccharidosis examined at autopsy (including examples of Hurler ...
N A, Parfrey, G M, Hutchins
openaire   +2 more sources

Deferiprone and hepatic fibrosis

Blood, 2003
We write to request that Wanless and colleagues correct the record on the efficacy and safety of deferiprone for treatment of transfusional iron overload by providing the data on hepatic iron omitted from their publication in Blood.
Gary M, Brittenham   +6 more
openaire   +2 more sources

Isoprostanes and hepatic fibrosis

Molecular Aspects of Medicine, 2008
After a brief introduction to oxidative stress, the discovery of F(2)-isoprostanes as specific and reliable markers of oxidative stress is described. Isoprostanes are also agonists of important biological effects. Since a relation between oxidative stress and collagen hyperproduction has been previously suggested and since lipid peroxidation products ...
COMPORTI, M.   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy